'The Moral Property of Women': Mifepristone, Fibroids and the Stakes of Suppressed Science

'The Moral Property of Women': Mifepristone, Fibroids and the Stakes of Suppressed Science

Despite mifepristone’s broad medical promise, its development has been repeatedly stymied by abortion opponents who fear wider availability would weaken their attempts to suppress abortion access. More than 26 million women in the U.S. are affected by fibroids, which are noncancerous growths of the uterus that can reach the size of a grapefruit or larger. Treatment too often defaults to invasive surgery, either removing the fibroids or performin…